Natera, Inc.
NASDAQ:NTRAMedical - Diagnostics & Research
+$2.23 today
- Market cap
- $41.98B
- Beta
- 1.54
- P/E (TTM)
- -143.0
- EPS (TTM)
- -$1.60
Volume 1.96M
Average 1.41M
NTRA Other Current Liabilities
Short-term obligations not reported separately, such as accrued expenses.
Natera, Inc.NASDAQ: NTRA
Other Current Liabilities · Q2 FY2026 · quarter ended Jun 2026
Other current liabilities rises 78.6% from a year ago
Other current liabilities stood at $115.58M at the end of Q2 FY2026, up 78.6% from a year earlier and down 24.7% from the prior quarter. Over 3 fiscal years it compounded at +17.5% a year.
Context
- Other current liabilities amounted to 4.3% of total assets at the end of Q2 FY2026, up 0.7 pp from a year earlier.
- Other current liabilities increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether other current liabilities keeps rising in the next quarterly balance sheet after a +78.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 102.11M USD
- Year-over-year change
- +39.1%
- 4-year CAGR
- +15.1%
| Period | Period end | Other Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 102.11M | +39.1% |
| FY2024 | 2024-12-31 | 73.39M | +6.2% |
| FY2023 | 2023-12-31 | 69.1M | +9.8% |
| FY2022 | 2022-12-31 | 62.96M | +8.3% |
| FY2021 | 2021-12-31 | 58.15M | — |
Other Current Liabilities vs competitors
How NTRA compares with its peers on the latest reported figures
- NTRA's Jun 2026 other current liabilities of $115.58M is the highest of the 8 companies compared; the peer median is $19.04M.
- Its year-over-year change of +78.6% is the 3rd highest of 8, against a peer median of +48.4%.
- Other current liabilities amounts to 4.3% of total assets for NTRA, versus a peer median of 3.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $115.58M | +78.6% | +17.5% | 4.3% | |
| Mar 2026 | $90.5M | +79.2% | +14.3% | 13.4% | |
| Mar 2026 | $53.65M | +775.7% | +25.4% | 4.6% | |
WGSGeneDx Holdings Corp. | Jun 2026 | $49.16M | +38.4% | +0.4% | 10.2% |
BLLNBillionToOne, Inc. | Jun 2026 | $19.04M | +69.4% | — | 2.6% |
| Mar 2026 | $11.29M | +48.4% | +10.2% | 3.5% | |
| Mar 2026 | $1.2M | -14.9% | +41.3% | 1.3% | |
| Jun 2026 | $662K | -98.3% | -7.9% | 0.0% | |
| Peer median (excluding NTRA) | $19.04M | +48.4% | +12.3% | 3.5% | |
Competitors are the stored peer set for NTRA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 84.39M | 466.09M | 642.1M | 945.59M | 1.08B |
| Short-term Investments | 829.9M | 432.3M | 236.88M | 22.69M | 0 |
| Net Receivables | 122.07M | 244.39M | 278.29M | 314.17M | 296.53M |
| Inventory | 26.91M | 35.41M | 40.76M | 44.74M | 68.44M |
| Other Current Assets | 228K | 33.63M | 60.52M | 48.64M | 55.83M |
| Total Current Assets | 1.09B | 1.21B | 1.26B | 1.38B | 1.5B |
| Property, Plant & Equipment (Net) | 124.53M | 164.33M | 167.75M | 248.2M | 349.73M |
| Goodwill | 0 | 0 | 0 | 0 | 141.07M |
| Intangible Assets | 0 | 0 | 0 | 0 | 373.71M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 109.69M |
| Other Non-current Assets | 18.82M | 18.33M | 15.4M | 36.72M | 36.9M |
| Total Non-current Assets | 143.35M | 182.66M | 183.15M | 284.92M | 1.01B |
| Total Assets | 1.24B | 1.39B | 1.44B | 1.66B | 2.51B |
| Account Payables | 27.21M | 31.15M | 15M | 34.92M | 33.16M |
| Short-term Debt | 50.05M | 80.35M | 80.4M | 80.36M | 80.32M |
| Tax Payables | 2.23M | 4.32M | 3.73M | 4.42M | 0 |
| Deferred Revenue | 7.4M | 10.78M | 16.61M | 19.75M | 24.91M |
| Other Current Liabilities | 58.15M | 62.96M | 69.1M | 73.39M | 102.11M |
| Total Current Liabilities | 218.96M | 310.5M | 307.27M | 344.05M | 441.23M |
| Long-term Debt | 280.39M | 281.65M | 282.95M | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 110.39M |
| Deferred Revenue (Non-current) | 21.32M | 20M | 19.13M | 16.84M | 17.06M |
| Other Non-current Liabilities | 1.48M | 0 | 0 | 7.84M | 108.47M |
| Total Non-current Liabilities | 364.23M | 378.23M | 369.1M | 121.27M | 354.4M |
| Total Liabilities | 583.18M | 688.73M | 676.37M | 465.32M | 795.62M |
| Common Stock | 10K | 11K | 11K | 12K | 14K |
| Retained Earnings | (1.39B) | (1.94B) | (2.38B) | (2.57B) | (2.78B) |
| Accumulated OCI | (2.29M) | (16.36M) | (3.09M) | (344K) | (258K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 653.3M | 705.74M | 765.33M | 1.2B | 1.71B |
| Total Debt | 397.23M | 446.22M | 441.99M | 187.12M | 214.38M |
| Net Debt | 312.85M | (19.87M) | (200.1M) | (758.47M) | (861.76M) |
Natera, Inc.
NASDAQ:NTRA
Intrinsic Alpha fair value
Locked
Current Price
$289.50
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.